The long-term objective is to study intracellular networks of cytokine signaling which mediate bladder fibrosis, a major process affecting bladder function and in the pathogenesis of renal disease. A fibrotic bladder has three primary components: 1) elevated extracellular matrix deposition, 2) inflammatory infiltration, and 3) increased abundance of activated fibroblasts. Together, it leads to bladder non-compliance and potentially kidney damage. Since each of these components impact one another, it has been difficult to study one without the other factors influencing our interpretation. Members of the TGFbeta family and its receptors, expressed in both stroma and epithelium, are especially elevated in fibrosis. In an effort to understand the specific role of TGFbeta signaling in the bladder stroma, a fibroblast-specific conditional knockout mouse of the type II TGFbeta receptor gene (Tgfbr2) was generated. The conditional knockout mice display hypercellular stroma in many tissues including the prostate, mammary gland, and pancreas. Interestingly the conditional knockout mouse displays bladder stromal hyperplasia in the male, but not the female mice of the same genotype. Together with known instances of androgen and estrogen signaling crosstalk with the TGFbeta signaling actions with regard to cell proliferation in various tissues, we hypothesize that estrogens and androgens play a role in bladder stromal hyperplasia in a TGFbeta-dependent manner. The androgen receptor is expressed early in bladder development and both estrogen receptor isoforms are expressed in the developing and adult bladder. The fibroblast conditional Tgfbr2 knockout mouse model and tissue recombination studies will be used to: 1) Characterize the role of estrogen in TGFbeta signaling on the mature bladder stroma and 2) Determine stromal TGFbeta signaling mechanisms involved in bladder development. Studying the function downstream targets, and regulation of TGFbeta in the context of differential estrogen or androgen signaling in vivo will allow a mechanistic understanding of an important component of bladder fibrosis. Results from these studies are directly relevant to potential non-invasive strategies in treating one of the most common pathologies of the bladder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DK069527-01
Application #
6856443
Study Section
Urologic and Kidney Development and Genitourinary Diseases Study Section (UKGD)
Program Officer
Mullins, Christopher V
Project Start
2004-09-30
Project End
2006-08-31
Budget Start
2004-09-30
Budget End
2005-08-31
Support Year
1
Fiscal Year
2004
Total Cost
$226,500
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Surgery
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Martinez-Ferrer, Magaly; Afshar-Sherif, Ali-Reza; Uwamariya, Consolate et al. (2010) Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol 176:98-107
Martinez-Ferrer, Magaly; Iturregui, Juan M; Uwamariya, Consolate et al. (2008) Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation. Am J Pathol 172:59-67
Starkman, Jonathan S; Martinez-Ferrer, Magaly; Iturregui, Juan M et al. (2008) Nicotinic signaling ameliorates acute bladder inflammation induced by protamine sulfate or cyclophosphamide. J Urol 179:2440-6
Sharif-Afshar, Ali-Reza; Donohoe, Jeffrey M; Pope 4th, John C et al. (2005) Stromal hyperplasia in male bladders upon loss of transforming growth factor-beta signaling in fibroblasts. J Urol 174:1704-7; discussion 1707